A historic shift in Canadian drug policy has taken place, as the government announce the use of psilocybin fungi for therapeutic treatment. Previously, these substances were severely restricted, but a mounting body of research suggests they potentially offer aid for emotional issues like depression. This change represents a substantial step toward